Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Esperion Therapeutics Inc (NASDAQ: ESPR) closed the day trading at $1.79 down -1.10% from the previous closing price of $1.81. In other words, the price has decreased by -$1.10 from its previous closing price. On the day, 9.38 million shares were traded. ESPR stock price reached its highest trading level at $1.825 during the session, while it also had its lowest trading level at $1.74.
Ratios:
For a better understanding of ESPR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.37 and its Current Ratio is at 1.85.
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 18, 2024, initiated with a Neutral rating and assigned the stock a target price of $4.
On December 17, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.
BofA Securities Downgraded its Neutral to Underperform on June 20, 2024, while the target price for the stock was maintained at $2.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 17 ’25 when Halladay Benjamin sold 9 shares for $2.27 per share. The transaction valued at 20 led to the insider holds 240,682 shares of the business.
Warren Eric sold 123 shares of ESPR for $278 on Jan 17 ’25. The Chief Commercial Officer now owns 159,998 shares after completing the transaction at $2.26 per share. On Jan 17 ’25, another insider, Warren Eric, who serves as the Officer of the company, bought 123 shares for $2.26 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 352692672 and an Enterprise Value of 476937952. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.19. Its current Enterprise Value per Revenue stands at 1.614 whereas that against EBITDA is 28.911.
Stock Price History:
The Beta on a monthly basis for ESPR is 1.00, which has changed by -0.24789917 over the last 52 weeks, in comparison to a change of 0.22208416 over the same period for the S&P500. Over the past 52 weeks, ESPR has reached a high of $3.94, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is -25.92%, while the 200-Day Moving Average is calculated to be -18.50%.
Shares Statistics:
Over the past 3-months, ESPR traded about 6.35M shares per day on average, while over the past 10 days, ESPR traded about 5165490 shares per day. A total of 195.44M shares are outstanding, with a floating share count of 195.08M. Insiders hold about 0.99% of the company’s shares, while institutions hold 65.91% stake in the company. Shares short for ESPR as of 1736899200 were 33978548 with a Short Ratio of 5.35, compared to 1734048000 on 25474270. Therefore, it implies a Short% of Shares Outstanding of 33978548 and a Short% of Float of 17.29.
